FORT COLLINS, Colo. – October 14, 2014 – Ventria Bioscience announced today that a research collaboration between scientists from Ventria Bioscience and the Bacterial Diseases Branch, Division of Vector-Borne Diseases at the U.S. Centers for Disease Control (CDC) has been selected to receive the 2014 Governor’s Award for High-Impact Research in the area of public health. The award, which is given every year by CO-LABS, recognizes the achievement and global impact of research coming out of federally funded laboratories based in the state of Colorado.
The research program, “An Oral Vaccine Produced in Rice Grain to Reduce the Risk of Lyme Disease,” was nominated for the award by Dr. C. Ben Beard, Chief of the Bacterial Diseases Branch at the CDC. The team that is conducting the research is led by co-principal investigators Barbara J. B. Johnson, Ph.D. of the CDC and Ning Huang Ph.D., vice president of research and development at Ventria Biosciences. The CO-LABS review committee has selected the program to be highlighted with an Honorable Mention in recognition of the team’s noteworthy effort to form strong public-private partnerships.
“Not only does Lyme disease present a significant human health risk in the United States, but it also serves as an excellent model for the control of zoonotic diseases—meaning those that can transmitted from animals to humans through intermediary species, such as the deer tick,” said Scott Deeter, president and chief executive officer of Ventria Bioscience. “Our work with the CDC is aimed at controlling this disease by producing and formulating orally available vaccines that can elicit a protective immune response in wild-animal reservoir populations.”
The award will be presented on November 12, 2014, at a reception held at the Denver Museum of Nature & Science.
CO-LABS educates the public, businesses, educational organizations, and government entities about the value of the federally funded laboratories, creates connections between these sectors, and supports retention and expansion of Colorado's scientific resources. www.co-labs.org.
About Ventria Bioscience Inc.
Ventria Bioscience is a biopharmaceutical company with a product pipeline targeting unmet medical needs. Ventria Bioscience’s patented ExpressTec biomanufacturing technology enables the development of new and cost-effective biologic products. For more information, visit www.Ventria.com.
# # #